Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bahn

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Brain, Behavior, and Immunity|May 2, 2015
Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorderM G Gottschalk, J D Cooper, M K Chan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 25, 2014
Randomized controlled trial of rituximab in patients with Graves' orbitopathyMarius N Stan, James A Garrity, Barbara G Carranza Leon, et al.
Journal of Cellular Biochemistry|January 1, 1986
Amplification of RNA and DNA specific for erb B in unbalanced 1;7 chromosomal translocation associated with myelodysplastic syndromeG E Woloschak, G W Dewald, R S Bahn, et al.
Thyroid : Official Journal of the American Thyroid Association|March 12, 2019
Clinical Experience with Rituximab and Intravenous Immunoglobulin for Pretibial Myxedema: A Case SeriesAnupam Kotwal, Adina F Turcu, Vikram Sonawane, et al.
Molecular Psychiatry|March 23, 2016
System-based proteomic and metabonomic analysis of the Df(16)A<sup>+/-</sup> mouse identifies potential miR-185 targets and molecular pathway alterationsH Wesseling, B Xu, E J Want, et al.
Translational Psychiatry|July 13, 2016
Serum proteomic profiles of depressive subtypesF Lamers, M Bot, R Jansen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2013
Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysisVishnu Sundaresh, Juan P Brito, Zhen Wang, et al.
Translational Psychiatry|August 27, 2014
Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophreniaN J M van Beveren, E Schwarz, R Noll, et al.
The Journal of Clinical Endocrinology and Metabolism|March 14, 2013
A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathyAdina F Turcu, Seema Kumar, Susanne Neumann, et al.
Molecular Psychiatry|May 21, 2009
Transcriptome analysis of male-female differences in prefrontal cortical developmentC S Weickert, M Elashoff, A B Richards, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Brain, Behavior, and Immunity|May 2, 2015
Discovery of serum biomarkers predicting development of a subsequent depressive episode in social anxiety disorderM G Gottschalk, J D Cooper, M K Chan, et al.
The Journal of Clinical Endocrinology and Metabolism|October 25, 2014
Randomized controlled trial of rituximab in patients with Graves' orbitopathyMarius N Stan, James A Garrity, Barbara G Carranza Leon, et al.
Journal of Cellular Biochemistry|January 1, 1986
Amplification of RNA and DNA specific for erb B in unbalanced 1;7 chromosomal translocation associated with myelodysplastic syndromeG E Woloschak, G W Dewald, R S Bahn, et al.
Thyroid : Official Journal of the American Thyroid Association|March 12, 2019
Clinical Experience with Rituximab and Intravenous Immunoglobulin for Pretibial Myxedema: A Case SeriesAnupam Kotwal, Adina F Turcu, Vikram Sonawane, et al.
Molecular Psychiatry|March 23, 2016
System-based proteomic and metabonomic analysis of the Df(16)A<sup>+/-</sup> mouse identifies potential miR-185 targets and molecular pathway alterationsH Wesseling, B Xu, E J Want, et al.
Translational Psychiatry|July 13, 2016
Serum proteomic profiles of depressive subtypesF Lamers, M Bot, R Jansen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 5, 2013
Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysisVishnu Sundaresh, Juan P Brito, Zhen Wang, et al.
Translational Psychiatry|August 27, 2014
Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophreniaN J M van Beveren, E Schwarz, R Noll, et al.
The Journal of Clinical Endocrinology and Metabolism|March 14, 2013
A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of Graves ophthalmopathyAdina F Turcu, Seema Kumar, Susanne Neumann, et al.
Molecular Psychiatry|May 21, 2009
Transcriptome analysis of male-female differences in prefrontal cortical developmentC S Weickert, M Elashoff, A B Richards, et al.
Pageof 19